The Effect of Integrated Leading, Managing and Governing for Result Model Towards Institutional Delivery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03639961 |
|
Recruitment Status :
Completed
First Posted : August 21, 2018
Last Update Posted : June 6, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The need for leading people, managing work, and governing organizations never changed over the civilization paths of society. However, people in every pole of the globe observe: over-led and under-managed, over-managed and under-governed, and even out of these organizations. These disparities have remained worse in the health system of developing countries like Ethiopia.
To date, Ethiopia put a goal of ending preventable child and maternal death, in achieving universal healthcare by 2035. Nevertheless, the investment on integrated leadership, management and governance is limited.
Therefore, this study hypothesize that institutional delivery are expressively linked with integrated health system leading, managing and governing for results model among health facilities staff in northwest Ethiopia?
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Leadership | Behavioral: Integrated leading, managing and governing for results model Behavioral: Traditional model | Not Applicable |
The investment on integrated health system leading, managing and governing for result model narrow down health system gaps.
The need to integrate these three distinct, but not hostile paths is that mostly: leading is people oriented process, managing is task oriented process and governing is organization oriented path.
Moreover, these paths are reflected even in a single person, task, or organization. Thus, testing and implementing integrated model is cost effective.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 418 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The integrated health system leading, managing and governing for results model is constructed from: leading practices, managing practice, and governing practices; moderating factors ; health services performance, and sustainable health outcomes and impact aligned with national health goals and Sustainable Development Goals (SDGs). |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | The Effect of Integrated Health System Leading, Managing and Governing for Result Model Towards Institutional Delivery Among Staff of Health Facilities in Northwest Ethiopia |
| Actual Study Start Date : | April 10, 2018 |
| Actual Primary Completion Date : | April 30, 2018 |
| Actual Study Completion Date : | October 30, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Staff of facilities for intervention
Intervention: Participants have been trained two times in six months period with integrated leading, managing and governing for results model.
|
Behavioral: Integrated leading, managing and governing for results model
Integrated leading, managing and governing for results model is an intervention launched to improve institutional delivery. |
|
Active Comparator: Staff of facilities for control
Intervention: Participants have been trained two times in six months period with traditional model.
|
Behavioral: Traditional model
Traditional model is a health service delivery model already in place in the government health system. |
- Institutional delivery [ Time Frame: Up to six months ]Increased institutional delivery. These have been assessed by institutional delivery follow up checklist. To declare that integrated leading, managing and governing for result model has an effect on institutional delivery improvement, on which it could be increased at least by 15%.
- Habit of institutional delivery [ Time Frame: two weeks ]Improvement on habit of institutional delivery has been explored from key informants, by key informant guideline. The explored data will be analyzed thematically, using the Qualitative Data Analysis (QDA) miner 4 software.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- All staff nominated by the respective districts that have been selected, but not deployed yet, for integrated health system leadership, management and governance for intervention by Amhara regional health office in the study setting have been included.
Exclusion Criteria:
- No exclusion criteria
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03639961
| Ethiopia | |
| North Achefer district | |
| Liben, Amhara, Ethiopia, 1000 | |
| Study Director: | G D Alene, PhD | Bahir Dar University |
| Responsible Party: | Yeshambel Agumas Ambelie, Lecturer, Bahir Dar University |
| ClinicalTrials.gov Identifier: | NCT03639961 |
| Other Study ID Numbers: |
090/18-04 |
| First Posted: | August 21, 2018 Key Record Dates |
| Last Update Posted: | June 6, 2019 |
| Last Verified: | June 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | The IPD will be shared up on the intervention study report has been published. |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) |
| Time Frame: | From October 2019 to June 2020 |
| Access Criteria: | For any humanistic purposes |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Integrated leading managing governing practices |

